
Bioorganic and Medicinal Chemistry Letters p. 453 - 458 (1999)
Update date:2022-07-30
Topics:
Marwood, Rachel D.
Riley, Andrew M.
Correa, Vanessa
Taylor, Colin W.
Potter, Barry V. L.
The synthesis of 1-O-[(3S,4R)-3-hydroxytetrahydrofuran-4-yl]-α-D- glucopyranoside 3,4,3'trisphosphate (7), a novel Ca2+ mobilising agonist at the Ins(1,4,5)P3 receptor, designed by excision of two motifs of adenophostin A is reported, defining a potential minimal structure for potent glucopyranoside-based agonists of Ins(1,4,5)P3 receptors.
View MoreZhejiang Newfine Industry Co.,Ltd.
Contact:+86-573-82262042
Address:No.225,Dongqing Road, garoms@163.com
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Chiral Quest (Suzhou) Company Ltd
website:http://www.chiralquest.com
Contact:+86-0512-62956066
Address:B1/9, 218 Xinghu Street, Suzhou Industrial Park
shandong zhongke taidou chemical co.,ltd
Contact:86-531-88682301
Address:Jinan shandong Province CHina
Doi:10.1039/c2ra23257j
(2013)Doi:10.1016/S0040-4039(02)00661-5
(2002)Doi:10.1021/jo010981d
(2002)Doi:10.1021/om020163r
(2002)Doi:10.1016/j.bmcl.2016.04.046
(2016)Doi:10.1055/s-2002-34214
(2002)